Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
N/A
-47,000 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
N/A
-65,500 Reduced 58.22%
47,000 $825,000
Q2 2021

Aug 16, 2021

SELL
N/A
-78,400 Reduced 41.07%
112,500 $1.09 Million
Q1 2021

May 17, 2021

SELL
N/A
-47,900 Reduced 20.06%
190,900 $2.05 Million
Q4 2020

Feb 16, 2021

SELL
N/A
-43,500 Reduced 15.41%
238,800 $3.51 Million
Q3 2020

Nov 16, 2020

SELL
N/A
-63,700 Reduced 18.41%
282,300 $4.01 Million
Q2 2020

Aug 14, 2020

BUY
N/A
26,200 Added 8.19%
346,000 $2.8 Million
Q1 2020

May 15, 2020

BUY
N/A
291,100 Added 1014.29%
319,800 $1.29 Million
Q3 2019

Nov 14, 2019

BUY
N/A
28,700 New
28,700 $9,000

About Trillium Therapeutics Inc.


  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.